<DOC>
	<DOCNO>NCT01037075</DOCNO>
	<brief_summary>Background : - Individuals schizophrenia significantly high tendency develop substance abuse dependence general population . For instance , people schizophrenia smoke much general population , many dependent street drug cocaine heroin . However , individual rarely include research study might provide information treatment schizophrenia substance abuse . - Strong evidence suggest schizophrenia substance dependence similar effect brain , affect attention , memory , eye movement . Other research indicate schizophrenia substance dependence affect part dopamine system , contribute problem brain function require treatment . These new development provide strong rationale study combination schizophrenia substance dependence . - Nicotine may help improve brain function think individual schizophrenia drug dependence . Some think memory problem experience individual treat nicotine . However , research need determine exactly nicotine affect individual schizophrenia drug dependence . Objectives : - To determine whether individual schizophrenia drug dependence show impairment test eye tracking , attention , memory compare healthy control subject . - To evaluate effect nicotine eye tracking , attention , memory individual schizophrenia substance dependence . Eligibility : - Current smoker ( least 10 cigarette per day past year ) 18 55 year age ( 1 ) diagnose schizophrenia/schizoaffective disorder , ( 2 ) diagnose schizophrenia/schizoaffective disorder currently use heroin and/or cocaine , ( 3 ) healthy individual family history psychotic illness . Design : - The study consist one training session three test session . Each session last 2 hour . - The training session introduce participant study test evaluate tolerance nicotine nasal spray use study . Participants tolerate high dose spray continue study . - At start test session , smoker one cigarette standardize time recent exposure nicotine . - During test session , participant receive placebo spray , low dose nicotine , high dose nicotine , ask perform test evaluate attention , memory , think task .</brief_summary>
	<brief_title>Influence Nicotine Cognitive Function Schizophrenic Patients With Without Comorbid Drug Dependence</brief_title>
	<detailed_description>Objective : Specific aim 1 : To test hypothesis individual comorbid schizophrenia drug dependence show impaired neurocognitive function anticipatory learn eyetracking , attention , memory performance compare healthy control subject . Specific aim 2 : To test hypothesis nicotine dose-dependently improve anticipatory learn eyetracking , attention , memory performance individual comorbid schizophrenia substance dependence . Study Population : Male nonpregnant-female smoker 18 55 year age , follow subject group : ( 1 ) patient DSM IV diagnosis schizophrenia ( 2 ) patient dual DSM IV diagnose schizophrenia heroin and/or cocaine dependence abuse , methadone beprenorphine maintenance ( 3 ) healthy individual family history psychotic illness . Design : This study double-blind , placebo control trial nicotine placebo nasal spray . Participants four visit . After train session , participant administer one dose ( 0 , 1 2 mg ) nicotine nasal spray 3 experimental session . The dose give 5 minute prior cognitive task battery . Outcome Measures : Vital sign , mood , performance task assess eye movement ( initiation latency , initiation acceleration , closed-loop pursuit gain ) , attention ( Continuous Performance Digit Symbol Substitution Tasks ) , memory ( delay recognition nback ) .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>INCLUSION CRITERIA : All participant must meet following criterion : age 18 60 smoke 10 cigarettes/day least past year Experimental group 1 2 , additional criterion : DSMIV diagnosis schizophrenia schizoaffective disorder ( assessment pertain diagnosis do MPRC screen protocol ) . Experimental group 2 , additional criterion : DSMIV diagnosis abuse dependence cocaine and/or heroin methadone buprenorphine maintenance . EXCLUSION CRITERIA : Comprehensive medical history : Exclusions : Heart disease , uncontrolled blood pressure ( persistent systolic 155 diastolic 95 ) , neurological condition ( stroke , seizure , history head injury ) , asthma , emphysema , chronic bronchitis , chronic obstructive pulmonary disease , pathology nasal passages precludes effective administration nicotine nasal spray . Drug Use Survey All subject : Exclude treatment tobacco dependence previous 6 month . Healthy control schizophrenic patient without comorbid drug abuse dependence : Exclude history alcohol substance dependence ever , alcohol substance abuse past year . Verify abstinence control substance urine screen ( Iscreen ) . Participants 2 group positive illicit drug ( exception marijuana ) exclude . Structured Clinical Interview DSMIV Healthy control : exclude current psychiatric disorder Urine pregnancy female : Exclude positive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 22, 2013</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Dual Diagnosis</keyword>
	<keyword>Nicotine Nasal Spray</keyword>
	<keyword>Drug Abuse/Dependence</keyword>
	<keyword>Cognitive Processes</keyword>
</DOC>